HealthDay on MSN42m
Zepbound Slashes Diabetes Risk in Obese Users
The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has ...
Biden's plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...
Biden wants drugs like Wegovy, Ozempic covered by Medicare, Medicaid
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by ...